SamSaterMDHematology and Oncology expert(He/Him)
Oncology • Port St. Lucie, FLHematologic Oncology
Founder and CEO HAS Consulting
Dr. Sater is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3502 SE Burk Ct
Port St. Lucie, FL 34984
Summary
- A cancer doctor focused on a patient's autonomy, safety, well-being, and survivorship as a real human!
Education & Training
Medical College of GeorgiaChief Residency, Hematology and Medical Oncology, 2016 - 2017
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2011 - 2014
Lebanese University School of MedicineClass of 2007
Certifications & Licensure
IL State Medical License 2024 - 2026
CO State Medical License 2024 - 2025
FL State Medical License 2021 - 2025
IN State Medical License 2024 - 2025
WI State Medical License 2024 - 2025
WV State Medical License 2024 - 2025
MD State Medical License 2017 - 2022
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers Start of enrollment: 2021 Oct 05
- Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer Start of enrollment: 2022 Apr 14
- Assessing the Benefit of Art & Music Therapy on Quality of Life in Patients With Breast Cancer Start of enrollment: 2021 Apr 21
Publications & Presentations
PubMed
- The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and Application.Anne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas, Mathew G Angelos, Nima Assad
Clinical Cancer Research. 2025-02-03 - 2 citationsEfficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung can...Arun Rajan, Houssein Abdul Sater, Osama Rahma, Richy Agajanian, Wiem Lassoued
Journal for Immunotherapy of Cancer. 2024-03-13 - 1 citationsPolymorphism in Men With Prostate Cancer Treated With Androgen Deprivation Therapy.Tristan M Sissung, Sarah Lochrin, Tyler Liu, Keith Schmidt, Jonathan Strope
Anticancer Research. 2023-09-01
Press Mentions
Top Doctor 2023December 4th, 2023
Dr SaterApril 7th, 2022
Updates on Immunotherapy for Lung Cancer PatientsApril 7th, 2022- Join now to see all
Committees
- Chair, Protocol Review Committee, Cleveland Clinic 2022 - Present
Research History
- Regional Research Director, Cancer Institute, Cleveland Clinic Florida2022 - Present
- Clinical Research Director, Cleveland Clinic Martin Health2021 - Present
- Head, Tumor MicroEnvironment Labortory, National Cancer Institute2017 - 2021
Professional Memberships
- Member
- Society for Immunotherapy of Cancer (SITC)Member
Other Languages
- Arabic, French, Russian
External Links
- Top Doctorhttps://www.castleconnolly.com/top-doctors/houssein-abdul-sater-medical-oncology-cc92413
- Novorêx Website http://Www.novorex.org
- Dr. Sater Boutique Clinic http://Www.consultdrsater.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
